Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mana Anvar"'
Autor:
Aliesha Griffin, Colleen Carpenter, Jing Liu, Rosalia Paterno, Brian Grone, Kyla Hamling, Maia Moog, Matthew T. Dinday, Francisco Figueroa, Mana Anvar, Chinwendu Ononuju, Tony Qu, Scott C. Baraban
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Griffin et al used CRISPR-Cas9 to generate 40 single-gene mutant zebrafish lines representing childhood epilepsies for which they evaluated larval phenotypes using electrophysiological, behavioral, neuro-anatomical, survival and pharmacological assay
Externí odkaz:
https://doaj.org/article/bfcda728977044beb624cc6204edc73f
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Dravet syndrome is a catastrophic epilepsy of childhood, characterized by cognitive impairment, severe seizures, and increased risk for sudden unexplained death in epilepsy (SUDEP). Although refractory to conventional antiepileptic drugs, emerging pr
Externí odkaz:
https://doaj.org/article/f7d03c9ed2a149ba8400a0d62730943e
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Epilepsy is a common chronic neurological disease affecting almost 3 million people in the United States and 50 million people worldwide. Despite availability of more than two dozen FDA-approved anti-epileptic drugs (AEDs), one-third of patients fail
Externí odkaz:
https://doaj.org/article/99a549dff9744caba03bb048fee2a463
Autor:
Aliesha Griffin, Brian P. Grone, Mana Anvar, Francisco Figueroa, Scott C. Baraban, Matthew T. Dinday, Carpenter C, Kyla R. Hamling, Rosalia Paterno, Moog M, Ononuju C, Qu T, J. Liu
Genetic engineering techniques have contributed to the now widespread use of zebrafish to investigate gene function, but zebrafish-based human disease studies, and particularly for neurological disorders, are limited. Here we used CRISPR-Cas9 to gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::650f0c47d305b20b267e182d412077e0
https://doi.org/10.1101/2021.02.11.430844
https://doi.org/10.1101/2021.02.11.430844
Autor:
Aliesha Griffin, Chinwendu Ononuju, Kyla R. Hamling, Francisco Figueroa, Scott C. Baraban, Rosalia Paterno, Colleen Carpenter, Maia Moog, Matthew T. Dinday, Brian P. Grone, Mana Anvar, Tony Qu, Jing Liu
Publikováno v:
Communications Biology
Communications biology, vol 4, iss 1
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Communications biology, vol 4, iss 1
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Genetic engineering techniques have contributed to the now widespread use of zebrafish to investigate gene function, but zebrafish-based human disease studies, and particularly for neurological disorders, are limited. Here we used CRISPR-Cas9 to gene
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Frontiers in Pharmacology, Vol 11 (2020)
Dravet syndrome is a catastrophic epilepsy of childhood, characterized by cognitive impairment, severe seizures, and increased risk for sudden unexplained death in epilepsy (SUDEP). Although refractory to conventional antiepileptic drugs, emerging pr
Publikováno v:
Griffin, A; Hamling, KR; Hong, S; Anvar, M; Lee, LP; & Baraban, SC. (2018). Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening. FRONTIERS IN PHARMACOLOGY, 9. doi: 10.3389/fphar.2018.00573. UCSF: Retrieved from: http://www.escholarship.org/uc/item/6jv422r5
Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacology, Vol 9 (2018)
Epilepsy is a common chronic neurological disease affecting almost 3 million people in the United States and 50 million people worldwide. Despite availability of more than two dozen FDA-approved anti-epileptic drugs (AEDs), one-third of patients fail
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18e3e88557566e88a549b61cd94f55e9
http://www.escholarship.org/uc/item/6jv422r5
http://www.escholarship.org/uc/item/6jv422r5